These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 26222750
1. A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Schwebke JR, Marrazzo J, Beelen AP, Sobel JD. Sex Transm Dis; 2015 Jul; 42(7):376-81. PubMed ID: 26222750 [Abstract] [Full Text] [Related]
2. Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study. Chavoustie SE, Jacobs M, Reisman HA, Waldbaum AS, Levy SF, Hillier SL, Nyirjesy P. J Low Genit Tract Dis; 2015 Apr; 19(2):129-34. PubMed ID: 24983350 [Abstract] [Full Text] [Related]
3. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. Chavoustie SE, Carter BA, Waldbaum AS, Donders GGG, Peters KH, Schwebke JR, Paull JRA, Price CF, Castellarnau A, McCloud P, Kinghorn GR. Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():13-18. PubMed ID: 31812702 [Abstract] [Full Text] [Related]
4. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Schwebke JR, Morgan FG, Koltun W, Nyirjesy P. Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602 [Abstract] [Full Text] [Related]
5. Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial. Fiorilli A, Molteni B, Milani M. Eur J Obstet Gynecol Reprod Biol; 2005 Jun 01; 120(2):202-5. PubMed ID: 15925053 [Abstract] [Full Text] [Related]
6. A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis. Waldbaum AS, Schwebke JR, Paull JRA, Price CF, Edmondson SR, Castellarnau A, McCloud P, Kinghorn GR. PLoS One; 2020 Jun 01; 15(5):e0232394. PubMed ID: 32365097 [Abstract] [Full Text] [Related]
7. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. Decena DC, Co JT, Manalastas RM, Palaypayon EP, Padolina CS, Sison JM, Dancel LA, Lelis MA. J Obstet Gynaecol Res; 2006 Apr 01; 32(2):243-51. PubMed ID: 16594932 [Abstract] [Full Text] [Related]
8. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis. Minozzi M, Gerli S, Di Renzo GC, Papaleo E, Ferrari A. Eur Rev Med Pharmacol Sci; 2008 Apr 01; 12(1):59-65. PubMed ID: 18401974 [Abstract] [Full Text] [Related]
9. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, Fehler G, Morrow A, Walker S, Vodstrcil LA, Fairley CK. PLoS One; 2012 Apr 01; 7(4):e34540. PubMed ID: 22509319 [Abstract] [Full Text] [Related]
10. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis. Nyirjesy P, McIntosh MJ, Steinmetz JI, Schumacher RJ, Joffrion JL. Sex Transm Dis; 2007 Apr 01; 34(4):197-202. PubMed ID: 17179772 [Abstract] [Full Text] [Related]
11. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J. J Womens Health (Larchmt); 2009 Nov 01; 18(11):1817-24. PubMed ID: 19951217 [Abstract] [Full Text] [Related]
12. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial. Zeron Mullins M, Trouton KM. Trials; 2015 Jul 26; 16():315. PubMed ID: 26210791 [Abstract] [Full Text] [Related]
13. Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis: A Randomized Controlled Trial. Mauck C, Hillier SL, Gendreau J, Dart C, Chavoustie S, Sorkin-Wells V, Nicholson-Uhl C, Perez B, Jacobs M, Zack N, Friend D. Obstet Gynecol; 2022 Jun 01; 139(6):1092-1102. PubMed ID: 35675606 [Abstract] [Full Text] [Related]
14. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Livengood CH, Soper DE, Sheehan KL, Fenner DE, Martens MG, Nelson AL, Ismail M, Thorp JM, Lappin M, Long BJ, Blackwelder T, Sweet RL, Sagov S. Sex Transm Dis; 1999 Mar 01; 26(3):137-42. PubMed ID: 10100770 [Abstract] [Full Text] [Related]
15. Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial. Khazaeian S, Navidian A, Navabi-Rigi SD, Araban M, Mojab F, Khazaeian S. Trials; 2018 Oct 26; 19(1):585. PubMed ID: 30367673 [Abstract] [Full Text] [Related]
16. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. J Fam Pract; 1995 Nov 26; 41(5):443-9. PubMed ID: 7595261 [Abstract] [Full Text] [Related]
17. Treatment for Symptomatic Bacterial Vaginosis: ARandomized Controlled Trial. Tariq N, Basharat A, Khan DH, Fahim A, Khan MH. J Coll Physicians Surg Pak; 2017 Nov 26; 27(11):686-689. PubMed ID: 29132478 [Abstract] [Full Text] [Related]
18. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis. Happel AU, Singh R, Mitchev N, Mlisana K, Jaspan HB, Barnabas SL, Passmore JS. BMC Infect Dis; 2020 Jul 10; 20(1):491. PubMed ID: 32650729 [Abstract] [Full Text] [Related]
19. [Sucrose gel for treatment of bacterial vaginosis: a randomized, double-blind, multi-center, parallel-group, phase III clinical trial]. Xiao BB, Zhang D, Chen R, Shi HR, Xin XR, Wang HL, Pang YC, Zhu SN, Yao C, Liao QP. Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec 18; 47(6):925-32. PubMed ID: 26679652 [Abstract] [Full Text] [Related]
20. Combined vaginal administration of nystatin, diiodohydroxyquin, and benzalkonium chloride versus oral metronidazole for the treatment of bacterial vaginosis. Chooprasertsuk W, Somboonporn W, Soontrapa S, Salang L, Amnatbuddee S. Int J Gynaecol Obstet; 2019 Jun 18; 145(3):261-267. PubMed ID: 30895611 [Abstract] [Full Text] [Related] Page: [Next] [New Search]